Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Jacob Chacko
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
oncology
cancer therapeutics |
| gptkbp:foundedYear |
2014
|
| gptkbp:founder |
gptkb:Scott_Lowe
Richard Heyman |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
ORIC Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:mission |
Overcoming resistance in cancer
|
| gptkbp:notableProduct |
ORIC-101
ORIC-114 ORIC-533 ORIC-944 |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ORIC
|
| gptkbp:website |
https://www.oricpharma.com/
|
| gptkbp:bfsParent |
gptkb:The_Column_Group
|
| gptkbp:bfsLayer |
7
|